Lawrence Wang

Prevalence of Baseline Polymorphisms for Potential Resistance to NS5A Inhibitors in Drug-Naive Individuals Infected with Hepatitis C Genotypes 1–4

D. Webster, M. Macartney, T. Haque, 2014, Antiviral therapy.